Day 1: The COVID Catalyst
We kicked off the Symposium with industry luminary, Noubar Afeyan, Chairman and Co-Founder of Moderna, which attracted a record 260 viewers. We continued the day with three industry-focused panels, starting with a panel on how COVID-19 boosted innovation across the continuum whether it be devices, therapeutics, diagnostics, supply chain, or the dissemination of needed products and services on a worldwide scale. The second panel addressed how digital health came into the spotlight in 2020 as a result of increased demand for virtual health. We closed the first day with a panel that discussed how the 2020 SPACs revolution will impact the IPO Market for 2021 and beyond.
- Fireside Chat with Noubar Afeyan, Chairman and Co-Founder of Moderna and Founder and CEO of Flagship Pioneering
- The COVID Catalyst: Driving Innovation Mainstream
- COVID Gives Digital Health a Shot in the Arm
- How the 2020 SPACs Revolution Will Impact the IPO Market for 2021 and Beyond